Tauriga Sciences Inc. announces mid-quarter updates for the second quarter of 2022

Tauriga Sciences Inc., a New York-based life science company, recently released promising financial updates for the second quarter of 2022. For the past few weeks, Tauriga has received inventory for its new, improved line of products. Unfortunately, Tauriga Sciences was one of the many companies that was hit hard by the COVID-related production delays between May and July of this year. All of these delays have had a negative impact on the company, with some of the aftermaths continuing to this day. However, since around August this year, the company has been able to resume operations at full speed. Tauriga Sciences has already achieved record-breaking quarterly sales in just six weeks of the quarter. Both the retail and e-comm divisions of the company are experiencing incredibly strong demand and growth. In addition, the recent launch of the Tauri Gum line of products accelerated the company's net revenue growth. As a result, the company's gross margin percentage continued to improve. Tauriga Sciences has communicated with numerous potential distributors, joint venture partners, professional athletes, large retail customers and international suppliers. The company is confident that it is able to enter into agreements and contracts that could potentially add value for shareholders. In addition, Tauriga Sciences recently added its product catalog to Amazon.com. The product range on this e-commerce platform now also includes caffeinated 50mg tauri gum (flavor Cherry Lime Rickey). As a result, the company's sales continue to grow on this platform as well. Finally, Tauriga Sciences says it will continue to advance the pharmaceutical development efforts that are currently taking place. These development efforts include creating a pharmaceutical, CBD-based version of the company's proprietary Tauri Gum product, which is believed to help manage nausea. This proposed new product is specifically intended for patients undergoing chemotherapy. Tauriga Sciences believes it will release a more comprehensive update on this particular development project in the near future. The company also believes it will be able to get regulatory approval for it.